Correlation Between Enlivex Therapeutics and Gemina Laboratories
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Gemina Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Gemina Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Gemina Laboratories, you can compare the effects of market volatilities on Enlivex Therapeutics and Gemina Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Gemina Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Gemina Laboratories.
Diversification Opportunities for Enlivex Therapeutics and Gemina Laboratories
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enlivex and Gemina is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Gemina Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gemina Laboratories and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Gemina Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gemina Laboratories has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Gemina Laboratories go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Gemina Laboratories
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Gemina Laboratories. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 1.44 times less risky than Gemina Laboratories. The stock trades about -0.03 of its potential returns per unit of risk. The Gemina Laboratories is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 35.00 in Gemina Laboratories on September 13, 2024 and sell it today you would earn a total of 20.00 from holding Gemina Laboratories or generate 57.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Gemina Laboratories
Performance |
| Timeline |
| Enlivex Therapeutics |
| Gemina Laboratories |
Enlivex Therapeutics and Gemina Laboratories Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Gemina Laboratories
The main advantage of trading using opposite Enlivex Therapeutics and Gemina Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Gemina Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will offset losses from the drop in Gemina Laboratories' long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Gemina Laboratories vs. Novo Nordisk AS | Gemina Laboratories vs. Genmab AS | Gemina Laboratories vs. Inhibikase Therapeutics | Gemina Laboratories vs. Purple Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |